Loading organizations...
AB Magnitude Ventures Group operates as a venture capital firm dedicated to fostering innovation within the healthcare sector. The firm specializes in providing strategic and financial support to scientific ventures, emphasizing a peer-to-peer approach where experienced scientists guide and collaborate with emerging scientific founders. Their methodology centers on understanding the intricate challenges inherent in developing healthcare innovations, aiming to convert scientific discoveries into viable enterprises.
The firm was established in 2021, emerging from an insight into the specific needs of scientist-entrepreneurs navigating the complex landscape of healthcare advancements. The founding team recognized a gap in the market for investors who not only provide capital but also offer deep scientific expertise and mentorship. This foundation allows them to serve as a knowledgeable partner for those translating intricate research into practical applications.
AB Magnitude Ventures Group primarily serves scientists and founders developing solutions in healthcare innovation. The firm's long-term vision is to be a committed partner in these endeavors, collectively working towards improving outcomes for patients and their families by bringing impactful scientific visions to fruition. They aim to nurture a community where scientific rigor meets entrepreneurial drive.
AB Magnitude Ventures Group has 1 tracked investment across 1 company. The latest tracked deal is $100.0M Series C in Odyssey Therapeutics in December 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2023 | Odyssey Therapeutics | $100.0M Series C | Lorence KIM | OrbiMed, SR ONE, Third Rock Ventures, Alexandria Venture Investments, Blackmars Capital, Catalio Capital, Colt Ventures, Creacion Ventures, CU Healthcare Innovation Fund, Fidelity Management & Research Company, Foresite Capital, General Catalyst, Global Bioaccess Fund, HBM Healthcare Investments, KB Investment, Racing Beach Ventures, T. Rowe Price Associates, Walleye Capital, Woodline Partners |